News
Hosted on MSN4mon
Mamaearth vs distributors; PharmEasy’s financialsfor FY24 were Rs 5,008 crore Revenue from lab tests and other services stood at Rs 652 crore. Context: This comes after PharmEasy underwent a major restructuring of its cap table, slashing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback